NPT Co (TSE:311A) EBIT: 円-71.31 Mil (TTM As of Apr. 2025)


TSE:311A NPT Co Ltd TSE:311A
9 GF Score
Price 円700.00
! 1 Warning Sign
View Full Analysis

What is NPT Co EBIT?

NPT Co TSE:311A 9 EBIT is 円-71.31 Mil as of Apr. 2025. GuruFocus rates TSE:311A with a GF Score™ of 9/100. The stock has 1 warning sign investors should review.

NPT Co's earnings before interest and taxes (EBIT) for the six months ended in Apr. 2025 was 円-154.19 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Apr. 2025 was 円-71.31 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. NPT Co's annualized ROC % for the quarter that ended in Apr. 2025 was -1,081.11%. NPT Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Apr. 2025 was %.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. NPT Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Apr. 2025 was -2.22%.


NPT Co  (TSE:311A) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

NPT Co's annualized ROC % for the quarter that ended in Apr. 2025 is calculated as:

ROC % (Q: Apr. 2025 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Oct. 2024 ) + Invested Capital (Q: Apr. 2025 ))/ count )
=-202.492 * ( 1 - 0% )/( (28.145 + 9.315)/ 2 )
=-202.492/18.73
=-1,081.11 %

where

Note: The Operating Income data used here is two times the semi-annual (Apr. 2025) data.

2. Joel Greenblatt's definition of Return on Capital:

NPT Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Apr. 2025 is calculated as:

ROC (Joel Greenblatt) %(Q: Apr. 2025 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Oct. 2024  Q: Apr. 2025
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-308.372/( ( (0 + max(-5.858, 0)) + (0 + max(-11.552, 0)) )/ 2 )
=-308.372/( ( 0 + 0 )/ 2 )
=-308.372/0
= %

where Working Capital is:

Working Capital(Q: Oct. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0 + 0 + 7.359) - (10.397 + 0 + 2.82)
=-5.858

Working Capital(Q: Apr. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0 + 0 + 15.939) - (25.44 + 0 + 2.051)
=-11.552

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Apr. 2025) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

NPT Co's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Apr. 2025 )
=-71.309/3210.601
=-2.22 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


NPT Co EBIT Related Terms


NPT Co EBIT Historical Data

* Premium members only.

The historical data trend for NPT Co's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

NPT Co EBIT Chart

NPT Co Annual Data
Trend Oct22 Oct23 Oct24
EBIT
-135.07 -177.26 -156.90

NPT Co Semi-Annual Data
Oct22 Oct23 Apr24 Oct24 Apr25 Apr26
EBIT Get a 7-Day Free Trial 0.00 -106.77 -50.13 -154.19 -71.31

TSE:311A vs ZTS, UTHR: EBIT Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, NPT Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


NPT Co EV-to-EBIT vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, NPT Co's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where NPT Co's EV-to-EBIT falls into.


TSE:311A
9GF Score
NPT Co Ltd TSE:311A
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

NPT Co EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Apr. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was 円-71.31 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of 円-71.31 Mil mean?
NPT Co (TSE:311A) has a EBIT of 円-71.31 Mil as of Apr. 2025. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on NPT Co.
Is NPT Co's EBIT too high?
NPT Co's current EBIT is 円-71.31 Mil. Overall, NPT Co has a GF Score™ of 9/100, reflecting its overall financial health beyond just this single metric.
How does NPT Co's EBIT compare to ZTS and UTHR?
NPT Co's EBIT of 円-71.31 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Drug Manufacturers company?
A good EBIT depends on the Drug Manufacturers industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on NPT Co. NPT Co's current EBIT is 円-71.31 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is NPT Co stock overvalued right now?
NPT Co (TSE:311A) has a current EBIT of 円-71.31 Mil. The current EBIT is 円-71.31 Mil. NPT Co's overall GF Score™ is 9/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For NPT Co (TSE:311A), the current EBIT is 円-71.31 Mil as of Apr. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

NPT Co Business Description

Address 3-5-7 Ariake, Room 9, 16th floor, TOC Ariake East Tower, Koto-ku, Tokyo, JPN, 135-0063
NPT Co Ltd is engaged in the Clinical development of new drugs and treatments for personalized medicine.
9GF Score

Get the complete analysis for TSE:311A

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円700.00
Price